BTIG analyst Ryan Zimmerman reiterated a Buy rating and $24.00 price target on Carlsmed Inc (NASDAQ: CARL).The analyst commented: "In ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE